Why Mining FAERS Alone Is a Signal Detection Blind Spot
For pharmacovigilance teams in the United States, the FDA Adverse Event Reporting System (FAERS) is the most familiar starting point for post-marketing safety surveillance. It is large, regulator-maintained, freely accessible through a public dashboard, and structured around the same ICH...
